Form 4: NeueHealth CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
George Lawrence Mikan III, CEO of NeueHealth, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On March 11, 2024, George Lawrence Mikan III, CEO of NeueHealth, sold 2,664 shares of common stock at a weighted average price of $8.11.
- On March 12, 2024, Mikan sold 1,598 shares at a weighted average price of $7.76.
- On March 13, 2024, Mikan sold 3,463 shares at a weighted average price of $7.30.
- These sales were to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions.
- Following these transactions, Mikan directly owns 75,662 shares of NeueHealth common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating routine stock sales for tax purposes. It doesn't convey any particularly positive or negative sentiment regarding the company's performance or future prospects.
Industry Context
This is a routine filing related to executive stock transactions and doesn't necessarily indicate a change in the company's outlook or performance.
Stakeholder Impact
- The stock sales could have a minor, temporary impact on the stock price.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Sale of 2,664 shares of common stock at a weighted average price of $8.11. |
| 03/12/2024 | Sale of 1,598 shares of common stock at a weighted average price of $7.76. |
| 03/13/2024 | Sale of 3,463 shares of common stock at a weighted average price of $7.30. |
| 03/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.